Left ventricular assist device as 'bridge to weight loss' prior to transplantation in obese patients with advanced heart failure

Annals of Transplantation

Volumn 16, Issue 1, 2011, Pages 5-13

  Dhesi, Pavittarpaul ^a   Simsir, Sinan A ^a   Daneshvar, Daniel ^a   Rafique, Asim ^a   Phan, Anita ^a   Schwarz, Ernst R ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Cardiac transplantation; Heart failure; Left ventricular assist device; Obesity; Weight loss

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CREATININE;

ADULT; AGED; ARTICLE; BODY MASS; BODY WEIGHT; CALORIC INTAKE; CARDIAC PATIENT; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENERGY EXPENDITURE; FEMALE; HEART ASSIST DEVICE; HEART EJECTION FRACTION; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; LEFT VENTRICULAR ASSIST DEVICE; LIFESTYLE MODIFICATION; MALE; MORBIDITY; MORTALITY; OBESITY; WEIGHT CHANGE; WEIGHT REDUCTION;

ADULT; AGED; BODY MASS INDEX; CARDIAC OUTPUT; ENERGY INTAKE; ENERGY METABOLISM; FEMALE; HEART FAILURE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; MALE; MIDDLE AGED; OBESITY; RISK FACTORS; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 79953304539     PISSN: 14259524     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Poirier P, Giles TD, Bray GA et al: Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association scientific statement on obesity and heart disease from the obesity committee of the council on nutrition, physical activity, and metabolism. Circulation, 2006; 113: 898-918
2. Flegal JN, Carrol MD, Ogden CL, Johnson CL: Prevalence and trends in obesity among US adults, 1999-2000. JAMA, 2002; 288: 1723-27
3. Lavie CJ, Milani RV: Obesity and cardiovascular disease: the Hippocrates paradox? J Am Coll Cardiol, 2003; 42: 677-79
4. Manson JE, Bassuk SS: Obesity in the United States: a fresh look at its high toll. JAMA, 2003; 289: 229-30
5. Sturm R, Well KB: Does obesity contribute as much to morbidity as poverty or smoking? Public Health, 2001; 115: 229-35
6. Rosamond W, Flegal K, Furie K et al: Heart disease and stroke statistics - 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation, 2008; 117(4): e25-146
7. Kenchaiah S, Sesso H, Gaziano M: Body Mass Index and Vigorous Physical Activity and the Risk of Heart Failure Among Men. Circulation, 2009; 119: 44-52
8. Hunt SA, Abraham WT, Chin MH et al; American College of Cardiology Foundation, American Heart Association: 2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll Cardiol, 2009; 53: e1-90
9. Westaby S: Destination therapy: time for real progress. Nat Clin Pract Cardiovasc Med, 2008; 5: 477-83
10. Grady KL, White-Williams C, Naftel D et al: Are preoperative obesity and cachexia risk factors for post heart trans-plant morbidity and mortality? A multi-institutional study of preoperative weight-height indices. Cardiac Transplant Research Database (CTRD) Group. J Heart Lung Transplant, 1999; 18: 750-63
11. Musci M, Loforte A, Potapov EV et al: Body mass index and outcome after ventricular assist device placement. Ann Thorac Surg, 2008; 86: 1236-42
12. Jonsson S, Hedblad B, Engstrom G et al: Influence of obesity on cardiovascular risk. Twenty-three-year follow-up of 22,025 men from an urban Swedish population. Int J Obes Relat Metab Disord, 2002; 26: 1046-53
13. Mikhail N, Golub MS, Tuck ML: Obesity and hypertension. Prog Cardiovasc Dis, 1999; 42: 39-58
14. Howard BV, Ruotolo G, Robbins DC: Obesity and dyslipidemia. Endocrinol Metab Clin North Am, 2003; 32: 855-67
15. Kenchaiah S, Evans JC, Levy D et al: Obesity and the risk of heart failure. N Engl J Med, 2002; 347: 305-13
16. Grundy SM: Metabolic Syndrome Pandemic. Arterioscler Thromb Vasc Biol, 2008; 28: 629-36
17. Jubber AS: Respiratory complications of obesity. Int J Clin Pract, 2004; 58: 573-80
18. Horwich TB, Fonarow GC, Hamilton MA et al: The Relationship Between Obesity and Mortality in Patient with Heart Failure. J Am Coll Cardiol, 2001; 38: 789-95
19. Romero-Corral A, Montrori VM, Somers VK et al: Association of body-weight with total mortality and with cardiovascular events in coronary disease: a systematic review of cohort studies. Lancet, 2006; 368: 666-78
20. Abdulla J, Kober L, Abildstrom SZ et al: Impact of obesity as a mortality predictor in high-risk patients with myocardial infarction or chronic heart failure: a pooled analysis of five registries. Eur Heart J, 2008; 29: 594-60
21. Frankenstein L, Zugck C, Nelles M et al: The obesity paradox in stable chronic heart failure does not persist after matching for indicators of disease severity and confounders. Eur J Heart Fail, 2009; 11: 1189-94
22. Kunju SU, Badarudeen S, Schwarz ER: Impact of Obesity in Patients With Congestive Heart Failure. Rev Cariovasc Med, 2009; 10: 142-51
23. Curtis JP, Selter JG, Wang Y et al: The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Internal Med, 2005; 165: 55-61
24. Gustafsson F, Kragelund CB, Torp-Pedersen C et al: Effect of obesity and being overweight on longterm mortality in congestive heart failure: influence of left ventricular systolic function. Eur Heart J, 2005; 26: 58064
25. Lietz K, John R, Burke EA et al: Pretransplant cachexia and morbid obesity are predictors of increased mortality after heart transplantation. Transplantation, 2001; 72: 277-83
26. Shiba N, Chan MC, Valantine HA et al: Longerterm risks associated with 10-year survival after heart transplantation in the cyclosporine era. J Heart Lung Transplant, 2003; 10: 1098-106
27. Baker AM, Levine TB, Goldberg AD, Levine AB: Natural history and predictors of obesity after orthotopic heart transplantation. J Heart Lung Transplant, 1992; 11: 1156-59
28. Rickenbacher PR, Kemna MS, Pinto FJ et al: Coronary artery intimal thickening in the transplanted heart: an in vivo intracoronary ultrasound study of immunologic and metabolic risk factors. Transplantation, 1996; 61: 46-53
29. Mehra MR, Kobashigawa J, Starling R et al: Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates - 2006. J Heart Lung Transplant, 2006; 25: 1024-42
30. Mano A, Fujita K, Uenomachi K et al: Body mass index is a useful predictor of prognosis after left ventricular assist system implantation. J Heart Lung Transplant, 2009; 5: 428-33
31. Butler J, Howser R, Portner PM, Pierson RN: Body Mass Index and Outcomes After Left Ventricular Assist Device Placement. Ann Thorac Surg, 2005; 79: 66-73
32. Zarraga IG, Schwarz ER: Impact of dietary patterns and interventions on cardiovascular health. Circulation, 2006; 114: 961-73
33. Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Arch Intern Med, 1998; 158: 1855-67
34. Kostis JB, Rosen RC, Cosgrove NM et al: Non-pharmacologic therapy improves functional and emotional status in congestive heart failure. Chest, 1994; 106: 996-1001
35. Beck-da-Silva L, Higginson L, Fraser M et al: Effect of Orlistat in obese patients with heart failure: a pilot study. Congest Heart Fail, 2005; 11: 118-23
36. McMahon FG, Fujioka K, Singh BN et al: Efficacy and safety of sibutramine in obese white and African American patients with hypertension: a 1-year, double-blind, placebo-controlled, multicenter trial. Arch Intern Med, 2000; 160: 2185-91
37. Tabet JY, Meurin P, Ben Driss A et al: Benefits of exercise training in chronic heart failure. Arch Cardiovasc Dis, 2009; 102: 721-30
38. Guyatt GH, Sullivan MJ, Thompson PJ et al: The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J, 1985; 132: 919-23
39. Bittner V: Determining prognosis in congestive heart failure: role of the 6-minute walk test. Am Heart J, 1999; 138: 593-96
40. Belardinelli R, Georgiou D, Cianci G, Purcaro A: Randomized, controlled trial of long-term moderate exercise training in chronic heart failure: effects on functional capacity, quality of life, and clinical outcome. Circulation, 1999; 99: 1173-82
41. McCloskey CA, Ramani GV, Mathier MA et al: Bariatric surgery improves cardiac function in morbidly obese patients with severe cardiomyopathy. Surg Obes Relat Dis, 2007; 3: 503-7
42. Macgregor AM, Boggs L: Drug Distribution in Obesity and following Bariatric Surgery: A Literature Review. Obes Surg, 1996; 6: 17-27
43. Kunju SU, Naim J, Czer L et al: Acute cellular transplant rejection following laparoscopic adjustable gastric banding in a morbidly obese patient post heart transplantation. J Cardiovasc Med, 2010; 11(9): 695-99
44. Ramani GV, McCloskey C, Ramanathan RC, Mathier MA: Safety and efficacy of bariatric surgery in morbidly obese patients with severe systolic heart failure. Clin Cardiol, 2008; 31: 516-20
45. Holdy K, Dembitsky W, Eaton LL et al: Nutrition assessment and management of left ventricular assist device patients. J Heart Lung Transplant, 2005; 24: 1690-96
46. el-Amir NG, Gardocki M, Levin HR et al: Gastrointestinal consequences of left ventricular assist device placement. ASAIO J, 1996; 42: 150-53
47. Spies C, Farzaneh-Far R, Na B et al: Relation of obesity to heart failure hospitalization and cardiovascular events in persons with stable coronary heart disease (from the Heart and Soul Study). Am J Cardiol, 2009; 104: 883-89